Elsevier obtains cancer drug compendia
Executive Summary
Scientific publisher announces definitive agreement to purchase Tampa, Fla.-based Gold Standard, Inc. a provider of drug and clinical information at the point of care. Gold Standard CEO Russ Thomas will continue to lead the organization as part of Elsevier, according to an April 19 release by both firms. With the purchase, Elsevier gains Gold Standard's eMPOWERx electronic prescribing tool and off-label oncology drug compendia currently in development. The deal comes as Medicare considers approving additional compendia for local carriers to use when making off-label coverage decisions [Editor's note: "The Pink Sheet" is published by Elsevier subsidiary F-D-C Reports]...